Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Dongfang Liu

Chief Medical Officer at Nuvation Bio Inc. (NUVB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M

Reported trades

Filed Stock Type Shares Price Value Since
Apr 21SEC NUVBNuvation Bio Inc. Sell Plan 50,00018,000 held (−74%) $5.02 $251K -0.4%
Dec 3SEC NUVBNuvation Bio Inc. Sell 150,00018,000 held (−89%) $7.82 $1.2M -36.1%
Nov 26SEC NUVBNuvation Bio Inc. Sell 10,00018,000 held (−36%) $7.50 $75K -33.3%
Nov 26SEC NUVBNuvation Bio Inc. Sell 10,00018,000 held (−36%) $8.00 $80K -37.5%
Nov 24SEC NUVBNuvation Bio Inc. Sell 20,00018,000 held (−53%) $7.00 $140K -28.6%
Nov 19SEC NUVBNuvation Bio Inc. Sell 15,00015,000 held (−50%) $4.77 $72K +4.8%
Nov 19SEC NUVBNuvation Bio Inc. Sell 15,00018,000 held (−45%) $5.10 $76K -2.0%
  • Sell

    Chief Medical Officer Dongfang Liu sold $251K of NUVB at $5.02 — cuts the stake by 74%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Dongfang Liu sold $1.2M of NUVB at $7.82 — cuts the stake by 89%.

  • Sell

    Chief Medical Officer Dongfang Liu sold $75K of NUVB at $7.50 — cuts the stake by 36%.

  • Sell

    Chief Medical Officer Dongfang Liu sold $80K of NUVB at $8.00 — cuts the stake by 36%.

  • Sell

    Chief Medical Officer Dongfang Liu sold $140K of NUVB at $7.00 — cuts the stake by 53%.

  • Sell

    Chief Medical Officer Dongfang Liu sold $72K of NUVB at $4.77 — cuts the stake by 50%.